Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences net income
Net income is the profit left for shareholders after every expense, interest and tax.
Panacea Life Sciences's net income for the twelve months ending Mar 31, 2024 was -$7.67M. For fiscal 2023 it was -$8.02M. The highest annual figure on record is -$296.57K in fiscal 2014.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$8.02M | – |
| FY2022 | Dec 31, 2022 | -$9.14M | – |
| FY2021 | Dec 31, 2021 | -$4.78M | – |
| FY2020 | Dec 31, 2020 | -$5.23M | – |
| FY2019 | Dec 31, 2019 | -$10.02M | – |
| FY2018 | Dec 31, 2018 | -$4.34M | – |
| FY2017 | Dec 31, 2017 | -$3.86M | – |
| FY2016 | Dec 31, 2016 | -$1.60M | – |
| FY2015 | Dec 31, 2015 | -$357.98K | – |
| FY2014 | Dec 31, 2014 | -$296.57K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | -$1.45M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.21M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.15M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.86M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.79M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.70M | – |
| Q3 FY2022 | Sep 30, 2022 | -$2.69M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.96M | -7308.8% |
| Q1 FY2022 | Mar 31, 2022 | -$2.78M | -850.6% |
| Q4 FY2021 | Dec 31, 2021 | -$2.09M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.09M | – |
| Q2 FY2021 | Jun 30, 2021 | $27.21K | -95.8% |
| Q1 FY2021 | Mar 31, 2021 | $370.65K | – |
| Q4 FY2020 | Dec 31, 2020 | -$87.50K | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.78M | – |
| Q2 FY2020 | Jun 30, 2020 | $655.22K | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.82M | – |
| Q4 FY2019 | Dec 31, 2019 | -$5.48M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.03M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.03M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.41M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.11M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.60M | – |
| Q2 FY2018 | Jun 30, 2018 | -$559.71K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.07M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.04M | – |
| Q3 FY2017 | Sep 30, 2017 | -$717.82K | – |
| Q2 FY2017 | Jun 30, 2017 | -$506.30K | – |
| Q1 FY2017 | Mar 31, 2017 | -$601.01K | – |
| Q4 FY2016 | Dec 31, 2016 | -$747.43K | – |
| Q3 FY2016 | Sep 30, 2016 | -$359.81K | – |
| Q2 FY2016 | Jun 30, 2016 | -$260.87K | – |
| Q1 FY2016 | Mar 31, 2016 | -$234.82K | – |
| Q4 FY2015 | Dec 31, 2015 | -$28.36K | – |
| Q1 FY2015 | Mar 31, 2015 | -$63.81K | – |
| Q4 FY2014 | Dec 31, 2014 | -$240.45K | – |
| Q3 FY2014 | Sep 30, 2014 | -$74.89K | – |
| Q2 FY2014 | Jun 30, 2014 | -$7.67K | – |
See a number that looks wrong?